抑郁症和焦虑症与多药在患有多发性硬化症的患者中的关联
Julia Baldt1,2, Niklas Frahm1, Michael Hecker1
1Section of Neuroimmunology, Department of Neurology, Rostock University Medical Centre, 18147 Rostock, Germany.
多药性,即使用五种或更多种药物,在多发性硬化症 (MS) 患者中很常见. 抑郁症的严重程度,而不是焦虑,与MS患者增加的药物使用和多药学显著相关.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多药性对患有多发性硬化症 (MS) 等慢性疾病的个人来说是一个重要的关注点.
- 了解多药学,心理健康和MS的并发症之间的关系对于患者的护理至关重要.
研究的目的:
- 调查MS患者中多种药物的流行情况.
- 评估多药学,焦虑/抑郁症严重程度和并发症的存在之间的关联.
主要方法:
- 这项研究涉及来自德国两个神经中心的374名多发性硬化症患者.
- 使用医院焦虑和抑郁量表 (HADS-A和HADS-D) 评估药物负担,并发性疾病,残疾和精神病学的措施.
主要成果:
- 较高的抑郁症得分 (HADS-D) 与增加的药物摄入量和多种药物 (p < 0.001) 有显著的关联.
- 焦虑严重程度 (HADS-A) 与多药性没有显著的相关性 (p = 0.413).
- 虽然并发症的发生频率与焦虑或抑郁症的严重程度没有差异,但并发症的总数与HADS-A (p = 0.045) 和HADS-D (p < 0.001) 评分都有正相关.
结论:
- 抑郁症症状是MS患者的一个重要问题,与多种药物和更多的并发症密切相关.
- 焦虑与多药性并没有直接相关,但与MS中多种并发性疾病的发生有关.
更多相关视频
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
